THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading

THURSDAY, July 6, 2023 (HealthDay News) — Loneliness might be a true heartbreaker for people with diabetes — raising their odds of a heart attack even more than unhealthy lifestyle habits do. That’s according to a new study of over 18,000 adults with the blood sugar disease. Researchers found thatContinue Reading